Atlas Trials

Validation Study of RETINA-AI Galaxy™, an Automated Diabetic Retinopathy Screening Device

Clinical trial NCT04774822 · COMPLETED

Trial details

NCT number
NCT04774822
Sponsor
RETINA-AI Health, Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
Diabetic RetinopathyDiabetic Eye ProblemsDiabetic Macular Edema
Start date
2021-03-25
Primary completion
2021-05-28
Enrollment
397

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.